CIK 0001746466 · Non-accelerated filer<br>Smaller reporting company
Equillium, Inc.
Sign in to watch- Ticker
- EQ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821554746
- Phone
- (858) 412-5302
- Business address
- 2223 AVENIDA DE LA PLAYA, SUITE 105, LA JOLLA, CA, 92037
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-07 | Connelly Stephen Chief Scientific Officer | Sale | −13,900 | $7.14 | $99K | 993,000 |
| 2021-06-07 | Connelly Stephen Chief Scientific Officer | Option exercise · Employee Stock Option (right to buy) | −8,490 | 0 | ||
| 2021-06-07 | Connelly Stephen Chief Scientific Officer | Option exercise · Employee Stock Option (right to buy) | −13,900 | 10,945 | ||
| 2021-06-04 | Connelly Stephen Chief Scientific Officer | Option exercise | +6,509 | $2.80 | $18K | 999,509 |
| 2021-06-04 | Connelly Stephen Chief Scientific Officer | Sale | −6,509 | $7.01 | $46K | 993,000 |
| 2021-06-04 | Connelly Stephen Chief Scientific Officer | Option exercise | +7,030 | $4.75 | $33K | 1,000,030 |
| 2021-06-04 | Connelly Stephen Chief Scientific Officer | Sale | −7,030 | $7.01 | $49K | 993,000 |
| 2021-06-04 | Connelly Stephen Chief Scientific Officer | Option exercise · Employee Stock Option (right to buy) | −6,509 | 8,490 | ||
| 2021-06-04 | Connelly Stephen Chief Scientific Officer | Option exercise · Employee Stock Option (right to buy) | −7,030 | 24,845 | ||
| 2021-05-26 | Keyes Jason A Chief Financial Officer | Sale | −5,000 | $6.50 | $32K | 115,720 |
| 2021-05-26 | Keyes Jason A Chief Financial Officer | Sale | −5,000 | $6.50 | $32K | 115,720 |
| 2021-05-26 | Pruzanski Mark Director | Grant or award · Stock Option (right to buy) | +20,770 | 20,770 | ||
| 2021-05-26 | McDermott Charles Douglas Director | Grant or award · Stock Option (right to buy) | +20,770 | 20,770 | ||
| 2021-05-26 | MANIAN BALA S Director | Grant or award · Stock Option (right to buy) | +20,770 | 20,770 | ||
| 2021-05-26 | DEMSKI MARTHA J Director | Grant or award · Stock Option (right to buy) | +20,770 | 20,770 | ||
| 2021-03-04 | Xu Yu (Katherine) Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2021-01-11 | Thomas Dolca Chief Medical Officer | Grant or award · Stock Option (right to buy) | +450,000 | 450,000 | ||
| 2021-01-04 | Connelly Stephen Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2021-01-04 | Zedelmayer Christine Sr. Vice President and COO | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2021-01-04 | BRADBURY DANIEL Executive Chairman | Grant or award · Stock Option (right to buy) | +36,000 | 36,000 |
Page 14 of 17 · 339 trades